BCAX Bicara Therapeutics Inc.: institutional ownership and insider trading
183 funds reported holding $2.14B of Bicara Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $32.1M, with 37 new positions and 9 funds selling out; over the last 12 months insiders bought $4.80M and sold $9.91M on the open market.
Famous investors holding BCAX
- D. E. Shaw (D. E. Shaw & Co.): $14.8M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $8.99M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $7.79M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.38M, 0.0% of the portfolio
Largest institutional holders of BCAX
- RA CAPITAL MANAGEMENT, L.P. — $215M
- T. Rowe Price Investment Management, Inc. — $188M
- Siren, L.L.C. — $166M
- Vestal Point Capital, LP — $156M
- Deep Track Capital, LP — $122M
- BlackRock, Inc. (BLK) — $114M
- Jupiter Topco LLC — $94.0M
- TPG GP A, LLC — $89.4M
- JANUS HENDERSON GROUP PLC (JHG) — $66.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $65.8M
Recent BCAX insider trades
- Sep 8, 2026: Cohlhepp Ryan sold 17,500 shares ($401K)
- Aug 10, 2026: Cohlhepp Ryan sold 18,750 shares ($525K)
- Aug 10, 2026: Mazumdar Claire sold 10,000 shares ($280K)
- Aug 10, 2026: Hyep Ivan sold 12,500 shares ($350K)
5%+ owners
- Vestal Point Capital, LP: 8.3% (Schedule 13G/A, filed May 15, 2026)
- Deep Track Capital, LP: 6.2% (Schedule 13G/A, filed May 15, 2026)
- BlackRock, Inc.: 5.4% (Schedule 13G, filed Jul 27, 2026)
- JANUS HENDERSON GROUP PLC: 5.1% (Schedule 13G, filed May 15, 2026)